Armistice Capital down over 18% YTD, investors can’t redeem due to new terms

Posted: May 5, 2025

Armistice Capital, a biotech-focused firm, lost money in February, March and April. March’s 19% loss was the largest monthly loss [Read More]
To access this content, you must be a member. Visit the Plans page for details.

Pershing Square to invest $900M in Howard Hughes Holdings

Posted: May 5, 2025

Bill Ackman’s Pershing Square will buy 9 million newly issued shares i.e. $900 million, in Howard Hughes Holdings. The purchase [Read More]
To access this content, you must be a member. Visit the Plans page for details.

Performance Round-Up II: CTAs whipsawed, stock pickers flat

Posted: May 2, 2025

Commodity trading advisors were whipsawed in April in volatile markets while stock pickers are mostly flat for the year. Multi-strategy [Read More]
To access this content, you must be a member. Visit the Plans page for details.

Performance Round-Up: Greenlight, Discovery and large multi-strategy firms put up solid gains in April

Posted: May 1, 2025

Despite ongoing volatility in the markets caused by President Trump’s tariff turmoil, multi-strategy firms ExodusPoint, Walleye Capital, Balyasny, Point72,  Citadel [Read More]
To access this content, you must be a member. Visit the Plans page for details.

Man Group stock downgraded by JPMorgan and Peel Hunt

Posted: May 1, 2025

UK-based investment bank Peel Hunt has reduced its forecast for the Man Group, lowering its rating, from “buy” to “add.” [Read More]
To access this content, you must be a member. Visit the Plans page for details.